Australia

Seeing Machines names Mitsubishi Electric Automotive America as a referral partner to drive accelerated sales of Guardian Generation 3 in The Americas

CANBERRA, Australia, Feb. 24, 2025 /PRNewswire/ -- Seeing Machines Limited (AIM: SEE), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, announces that Mitsubishi Electric Automotive America, Inc. ("MEAA") has signed a...

2025-02-24 20:00 2523

FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA

* YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1 * First-in-class novel PTH replacement therapy * Australia becomes the first country to obtain Marketing Authorisation for YORVIPATH s...

2025-02-21 00:01 2748

Silicon Quantum Computing achieves world-leading accuracy of Grover's algorithm without error correction

SYDNEY, Feb. 20, 2025 /PRNewswire/ -- Silicon Quantum Computing (SQC), a pioneer in quantum computing and atomic manufacturing, today announced that it has demonstrated world-leading accuracy in the operation of Grover's algorithm without error correction, i.e. in its native pure form. This prove...

2025-02-20 18:10 2419

Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA

SYDNEY, Feb. 19, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce thatthe Un...

2025-02-19 22:09 2729

ClassDojo CTO backs kid-tech gaming app, Polymath in $1M raise

AUCKLAND, New Zealand, Feb. 17, 2025 /PRNewswire/ -- Kid-tech startup Polymath has secured$1M USD in funding with notable investment from ClassDojo CTO Liam Don in their first angel round, followed by a venture-backed pre-seed raise co-led by Blackbird Ventures and GD1. This investment accelerate...

2025-02-18 02:30 2445

An independent third-party performance assessment confirms that the Aquarius AQ 150 engine demonstrates 25% higher efficiency than the world's leading engines, operates on multiple fuel types, and is significantly lighter than existing alternatives

As a reminder, Aquarius' innovative systems generate and supply clean electricity, designed to enable ultra-fast charging for electric vehicles in the rapidly growing EV market. Aquarius' systems are smaller and more efficient than existing market solutions and do not depend on the power grid. A...

2025-02-14 06:00 6785

Nuix Awarded Patent for Breakthrough Deep Learning Technology for Training AI

SYDNEY, Feb. 10, 2025 /PRNewswire/ -- Nuix Ltd. (ASX: NXL), a global leader in data processing, investigative analytics and intelligent software, has today announced it has been granted a patent for pioneering a novel technology system that uses advanced deep learning techniques to better train a...

2025-02-11 11:35 2010

Canadian Solar's e-STORAGE to Deliver 960 MWh of Energy Storage Systems for Copenhagen Infrastructure Partners in Australia

KITCHENER, ON, Feb. 10, 2025 /PRNewswire/ -- Canadian Solar Inc . (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced thate-STORAGE , which is part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. ("CSI Solar"), ...

2025-02-10 20:00 3245

Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment

PERTH, Australia, Feb. 6, 2025 /PRNewswire/ -- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company brings hope to epilepsy patients. For thousands of patients with refractory epilepsy—commonly referred to as drug-resistant epilepsy—the search for effective trea...

2025-02-06 05:00 2498

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

Late-stage Alzheimer's trial opens 10 new sites in USA, with results due in 2025 and 2026 SYDNEY, Feb. 5, 2025 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary name of 'emestedastat' to Actinogen for its Xaname...

2025-02-05 22:18 2849

Breinrock and the Sustainable Revolution in Financial Technology

LONDON, Feb. 4, 2025 /PRNewswire/ -- The Fintech industry continues to thrive, driving innovation and reshaping global finance. At the forefront of this revolution is Breinrock, a rising star in the financial technology landscape, recognised for its pioneering approach to cross-border payments. A...

2025-02-05 01:31 2410

JOHNNY BIGG EXPANDS RETAIL PRESENCE WITH NEW CONCESSIONS IN BELK STORES

Providing on-trend fashion for big and tall men across the USA. SYDNEY, Jan. 14, 2025 /PRNewswire/ -- Johnny Bigg , a fashion-forward brand made specifically for big and tall men, is excited to announce its retail debut in five Belk stores. This milestone highlights ...

2025-01-15 12:34 2169

Hansen Strengthens Community Solar Reach Across the United States, Targets New Growth Opportunities

Hansen today partners with Community Solar developers across ten US states; primed to enter seven more as customer operations expand MELBOURNE, Australia, Jan. 14, 2025 /PRNewswire/ -- Hansen Technologies (ASX:HSN), a leading global provider of software and services to the energy, utilities, com...

2025-01-14 21:49 2107

TESSAN Unveils Latest Travel Charging Solutions at CES 2025, Reinforcing User-Centric Brand Philosophy

LAS VEGAS, Jan. 8, 2025 /PRNewswire/ -- At CES 2025, which opened on January 7 and runs untilJanuary 10, leading charging solution provider TESSAN captivated attendees with its latest travel charging solutions. The brand further solidified its commitment to a user-centric philosophy through engag...

2025-01-09 03:02 2108

Seeing Machines to showcase world-leading interior sensing solutions at CES 2025

CANBERRA, Australia, Jan. 8, 2025 /PRNewswire/ -- Seeing Machines Limited (AIM: SEE), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, will showcase its world-leading interior sensing technology at the Consumer Electr...

2025-01-08 15:00 2426

Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044

WUHAN, China, Jan. 2, 2025 /PRNewswire/ -- Hanx Biopharmaceuticals, CO. Ltd, an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet medical need diseases, today announced the first patient dosing inAustralia on Dec 30, 2024 for Phase 1 cl...

2025-01-03 01:43 2700

Social Media Ban in Australia: What Online Casinos Can Learn on Responsible Gambling Practices? - Insights from CasinoAus

SYDNEY, Dec. 23, 2024 /PRNewswire/ -- Australia's social media ban for under 16's is a revolutionary step in internet regulation, and highlights an opportunity for the online casino industry to prioritise safe and enjoyable user experiences. Accor...

2024-12-24 00:12 2952

CStone Announces Submission of Clinical Trial Application in Australia for CS2009, an Innovative PD-1/VEGF/CTLA-4 Trispecific Antibody

SHANGHAI, Dec. 22, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, announced today the submission of clinical trial application inAustralia for CS2009 (PD-1/VEGF/CT...

2024-12-23 08:00 2683

DAZN ADVANCES GLOBAL EXPANSION WITH ACQUISITION OF FOXTEL, A LEADING AUSTRALIAN SPORTS AND ENTERTAINMENT MEDIA GROUP

* Milestone deal for DAZN's position as the global home of sport. * This acquisition establishes DAZN's sports platform in Australia, one of the world's most attractive sports markets. * Foxtel Group will leverage DAZN's global reach, industry-leading technology and extensive content portfol...

2024-12-23 07:43 2444

Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical

Highlights * Clarity has developed a proprietary fibroblast activation protein (FAP)-targeted radiopharmaceutical product that can be used with the perfect pairing of copper isotopes for the diagnosis and treatment of cancer. * The product, termed SAR-bisFAP, has shown strong tumour targeting...

2024-12-18 22:03 2214
1 ... 3456789 ... 49

Week's Top Stories